Correlation Between Day One and Voyager Therapeutics

Can any of the company-specific risk be diversified away by investing in both Day One and Voyager Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Voyager Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Day One Biopharmaceuticals and Voyager Therapeutics, you can compare the effects of market volatilities on Day One and Voyager Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Voyager Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Voyager Therapeutics.

Diversification Opportunities for Day One and Voyager Therapeutics

0.82

Correlation Coefficient

Day One  Voyager Therapeutics

Very poor diversification

The 3 months correlation between Day and Voyager is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Voyager Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Voyager Therapeutics and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Voyager Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Voyager Therapeutics has no effect on the direction of Day One i.e., Day One and Voyager Therapeutics go up and down completely randomly.

Pair Corralation between Day One and Voyager Therapeutics

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Voyager Therapeutics. In addition to that, Day One is 1.13 times more volatile than Voyager Therapeutics. It trades about -0.14 of its total potential returns per unit of risk. Voyager Therapeutics is currently generating about -0.16 per unit of volatility. If you would invest  559.00  in Voyager Therapeutics on December 28, 2024 and sell it today you would lose (192.00) from holding Voyager Therapeutics or give up 34.35% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	98.36%
Values	Daily Returns

Day One Biopharmaceuticals  vs.  Voyager Therapeutics

Day One Biopharmaceu

Risk-Adjusted Performance

Very Weak

Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Voyager Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Voyager Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Day One and Voyager Therapeutics

The main advantage of trading using opposite Day One and Voyager Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Voyager Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Voyager Therapeutics will offset losses from the drop in Voyager Therapeutics' long position.

The idea behind Day One Biopharmaceuticals and Voyager Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.